Metraipolis › archive › dc_4805877e05f9

Identification of Proteomic Biomarkers and Therapeutic Targets for Vitiligo Using a Two-Sample Proteome-Wide Mendelian Randomization Approach — Europe PMC PMID:40856249

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40856249
DOI
10.1111/jocd.70420
License (as archived)
solo-consultazione
Archived
2026-11-10T05:16:24.874Z
SHA-256 of the archived text
378a6d5d3307bc5ff905f3fecf442fb8015dcd3c923a2d165edd3dec312906fb
Stable URL of this page
https://metraipolis.com/documento/dc_4805877e05f9

How to cite

Identification of Proteomic Biomarkers and Therapeutic Targets for Vitiligo Using a Two-Sample Proteome-Wide Mendelian Randomization Approach — Europe PMC PMID:40856249 — Europe PMC (en), https://europepmc.org/article/MED/40856249 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4805877e05f9 (Metraipolis archive dc_4805877e05f9, sha256 378a6d5d3307bc5ff905f3fecf442fb8015dcd3c923a2d165edd3dec312906fb)
BibTeX
@misc{dc4805877e05f9,
  title = {Identification of Proteomic Biomarkers and Therapeutic Targets for Vitiligo Using a Two-Sample Proteome-Wide Mendelian Randomization Approach — Europe PMC PMID:40856249},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40856249},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4805877e05f9; sha256 378a6d5d3307bc5ff905f3fecf442fb8015dcd3c923a2d165edd3dec312906fb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40856249. Agents can read the archived copy with the MCP tool read_document.